10.1 Carbohydrates
Key Takeaways
- Phosphofructokinase-1 is the committed step of glycolysis: AMP and fructose-2,6-bisphosphate activate it; ATP and citrate inhibit it.
- Hexokinase has a low Km (~0.1 mM) and is inhibited by glucose-6-phosphate; liver glucokinase has a high Km (~10 mM) and is not product-inhibited by glucose-6-phosphate.
- Gluconeogenesis bypasses the three irreversible glycolytic steps with pyruvate carboxylase (biotin), PEPCK, fructose-1,6-bisphosphatase, and glucose-6-phosphatase.
- The oxidative pentose phosphate pathway committed enzyme is glucose-6-phosphate dehydrogenase; NADPH keeps glutathione reduced, so G6PD deficiency produces oxidant hemolysis.
- SGLT1 cotransports glucose and galactose with sodium at the enterocyte apex; GLUT5 carries fructose; GLUT2 exits across the basolateral membrane.
Chemistry is Session 2, and carbohydrates open the domain
Chemistry is 13% of NBCE Part I and is tested in Session 2 with Pathology and Microbiology. Inside Chemistry, Carbohydrates are 13%. The official test plan asks for catabolic and anabolic pathways, structure/properties/function, and nutritional concepts (food sources and digestion). Citric acid cycle and the electron-transport chain are Biochemical Energetics in the next chapter; stop this section at pyruvate and the NADPH/ribose branches that actually belong to carbohydrate metabolism.
Quick Answer: Glucose is a D-aldohexose stored as glycogen (α-1,4 chains, α-1,6 branches). PFK-1 is the committed glycolytic step (AMP and fructose-2,6-bisphosphate on; ATP and citrate off). Gluconeogenesis uses pyruvate carboxylase, PEPCK, fructose-1,6-bisphosphatase, and glucose-6-phosphatase. PPP NADPH protects red cells. SGLT1/GLUT5/GLUT2 handle absorption.
Structure, stereochemistry, and glycosidic bonds
A monosaccharide is a polyhydroxy aldehyde (aldose) or ketone (ketose). Glucose is an aldohexose; fructose is a ketohexose. Fischer projection D/L is set by the chiral carbon farthest from the carbonyl: almost all mammalian sugars are D. Epimers differ at one chiral carbon (glucose/galactose at C4; glucose/mannose at C2). Anomers differ at the carbonyl carbon after ring closure: α versus β. In solution, glucose mutarotates through the open chain to an equilibrium mixture (~36% α, ~64% β).
Haworth rings: glucose usually a pyranose (six-membered); fructose in sucrose is a furanose (five-membered). The anomeric carbon is the only carbon bonded to two oxygens. If that OH is free, the sugar is reducing (can open and reduce a cupric reagent). If the anomeric carbons of both partners are locked in a glycosidic bond, the disaccharide is nonreducing.
| Molecule | Linkage | Reducing? | Physiologic note |
|---|---|---|---|
| Maltose | Glc-α-1,4-Glc | Yes | Starch/glycogen digest product |
| Isomaltose | Glc-α-1,6-Glc | Yes | Branch leftover after α-amylase |
| Lactose | Gal-β-1,4-Glc | Yes | Milk sugar; lactase (β-galactosidase) |
| Sucrose | Glc-α-1,2-β-Fru | No | Table sugar; sucrase-isomaltase |
| Trehalose | Glc-α-1,1-α-Glc | No | Fungi/insects; trehalase |
| Glycogen | α-1,4 chains, α-1,6 branches every ~8–12 residues | One reducing end | Liver and muscle storage |
| Amylose | Linear α-1,4 | One reducing end | Plant starch |
| Amylopectin | α-1,4 plus α-1,6 every ~24–30 | One reducing end | Plant starch |
| Cellulose | β-1,4-Glc | One reducing end | Humans lack cellulase |
| Hyaluronan | GlcA-β-1,3-GlcNAc repeats | Polymer | IVD nucleus and synovial fluid GAG |
Glycosaminoglycans (GAGs) are repeating disaccharides, usually a uronic acid plus an amino sugar, often sulfated. Aggrecan in the intervertebral disc nucleus pulposus carries chondroitin sulfate and keratan sulfate. The polyanion holds water; that is carbohydrate function, not a Part II disc-herniation lecture. Glycoproteins (N-linked on Asn, O-linked on Ser/Thr) and glycolipids decorate membranes; blood-group antigens are oligosaccharides on red-cell glycolipids and glycoproteins.
Worked stereochemistry item. Galactose is the C4 epimer of glucose. UDP-galactose 4-epimerase (GALE) interconverts UDP-Glc and UDP-Gal so dietary galactose can enter glucose pathways and so glycoprotein synthesis can proceed when lactose is not on the plate.
Digestion, food sources, and absorption
Dietary carbohydrate in a mixed human diet is mostly starch (amylose and amylopectin), sucrose, lactose, and smaller amounts of fructose, glucose, and poorly digested fiber (cellulose, some pectins). Salivary α-amylase (ptyalin) and pancreatic α-amylase are endoglucosidases that attack internal α-1,4 bonds and spare α-1,6 branches and the terminal reducing end. Products are maltose, maltotriose, and α-limit dextrins.
Brush-border oligosaccharidases finish the job: maltase-glucoamylase, sucrase-isomaltase (sucrose plus α-1,6 branches), lactase, trehalase. Lactase declines after weaning in much of the world; undigested lactose draws water and is fermented to gas — osmotic diarrhea, not an allergy.
| Transporter | Location | Cargo | Driving force |
|---|---|---|---|
| SGLT1 (SLC5A1) | Enterocyte (and renal) apical | Glucose and galactose | Na+ electrochemical gradient (secondary active) |
| GLUT5 (SLC2A5) | Enterocyte apical | Fructose | Facilitated diffusion |
| GLUT2 (SLC2A2) | Enterocyte basolateral; liver; β-cell | Glucose, galactose, fructose | Facilitated; high Km |
| GLUT1 | RBC, blood-brain barrier, glia | Glucose | Low Km; constitutive |
| GLUT4 | Skeletal muscle, adipose | Glucose | Insulin-recruited to the membrane |
| GLUT3 | Neurons | Glucose | Very low Km |
Ouabain-sensitive Na+/K+-ATPase on the basolateral membrane keeps intracellular sodium low so SGLT1 can run. Oral rehydration solution works because glucose-stimulated sodium (and water) absorption survives in many diarrheas.
Exam trap: insulin does not gate intestinal GLUT2/SGLT1 the way it gates muscle GLUT4. A fed person absorbs starch whether or not insulin has been injected. Insulin does move GLUT4 to the sarcolemma so muscle and fat can clear post-prandial glucose.
Glycolysis: ten steps, three irreversible, one committed
Glycolysis converts glucose to two pyruvate in the cytosol. Energy investment is 2 ATP (hexokinase/glucokinase and PFK-1). Payoff is 4 ATP (phosphoglycerate kinase and pyruvate kinase) plus 2 NADH (glyceraldehyde-3-phosphate dehydrogenase). Net: 2 ATP + 2 NADH per glucose. Anaerobic tissues (RBC always; exercising muscle) regenerate NAD+ by lactate dehydrogenase, so the net is 2 ATP and 2 lactate, no NADH leftover.
| Enzyme | Reaction | Regulation you must recite |
|---|---|---|
| Hexokinase (most tissues) | Glucose → G6P | Low Km; inhibited by G6P |
| Glucokinase (liver, β-cell) | Glucose → G6P | High Km; induced by insulin; sequestered by GKRP when F6P is high; fructose-1-phosphate releases it |
| PFK-1 | F6P + ATP → F-1,6-BP + ADP | Committed step. Activators: AMP, fructose-2,6-bisphosphate. Inhibitors: ATP, citrate |
| Pyruvate kinase (liver) | PEP → pyruvate + ATP | Feed-forward by F-1,6-BP; inhibited by ATP and alanine; glucagon/PKA phosphorylation inactivates liver PK |
Phosphofructokinase-1 (PFK-1) is the enzyme to know cold. ATP occupancy of an allosteric site raises the K0.5 for fructose-6-phosphate and flattens the sigmoid. AMP reverses that. Citrate reports that the mitochondria are full and further glycolytic carbon is not needed. Fructose-2,6-bisphosphate is the most potent feed-forward activator in liver and the hormone-coupling device:
- The bifunctional enzyme PFK-2/FBPase-2 both makes and breaks F-2,6-BP.
- Insulin (fed liver): protein phosphatase dephosphorylates the liver bifunctional enzyme → PFK-2 on → F-2,6-BP rises → PFK-1 on → glycolysis.
- Glucagon (fasted liver): cAMP-PKA phosphorylates the bifunctional enzyme → FBPase-2 on → F-2,6-BP falls → PFK-1 off, and the same fall de-inhibits fructose-1,6-bisphosphatase so gluconeogenesis can run.
- Muscle PFK-2 is a different isoform and is not turned off by glucagon/PKA the same way — muscle is not in the business of exporting glucose.
Pyruvate fates (do not dump the whole TCA map here): aerobic tissues send pyruvate into mitochondria via pyruvate dehydrogenase (TPP, lipoamide, CoA, FAD, NAD+) to acetyl-CoA. PDH is inactivated by phosphorylation (PDH kinase, stimulated by acetyl-CoA, NADH, ATP) and reactivated by PDH phosphatase (stimulated by insulin and Ca2+). Cytosolic pyruvate can also transaminate to alanine (Cahill cycle) or be reduced to lactate (Cori cycle).
2,3-bisphosphoglycerate (2,3-BPG) in red cells is a glycolytic shunt (Rapoport-Luebering) that lowers hemoglobin O2 affinity. That is why a glycolysis-block in RBCs can present as both hemolysis and a change in the oxygen curve — chemistry meeting respiratory physiology.
Gluconeogenesis: four bypasses, not a simple reverse
Liver (and to a lesser extent kidney cortex) can make free glucose. Muscle cannot, because it lacks glucose-6-phosphatase. Reversing glycolysis is thermodynamically illegal at the three kinase steps, so gluconeogenesis uses four enzymes:
- Pyruvate carboxylase (mitochondrial, biotin, acetyl-CoA is an obligate allosteric activator) carboxylates pyruvate to oxaloacetate. No acetyl-CoA, no gluconeogenesis — a starved liver that cannot β-oxidize (carnitine defect, CPT-I defect) becomes hypoglycemic.
- PEPCK decarboxylates and phosphorylates oxaloacetate to PEP (GTP). Cytosolic PEPCK is glucagon/cortisol-induced and insulin-repressed.
- Fructose-1,6-bisphosphatase hydrolyzes F-1,6-BP. Inhibited by AMP and by F-2,6-BP — the mirror of PFK-1.
- Glucose-6-phosphatase (endoplasmic reticulum of liver and kidney; glucose-6-phosphate translocase plus catalytic subunit) releases free glucose into blood.
Carbon sources: lactate (Cori), glucogenic amino acids (especially alanine), glycerol from lipolysis (enters at DHAP via glycerol kinase — liver has it, adipose does not), and propionyl-CoA from odd-chain fatty acids. Acetyl-CoA from even-chain fat cannot make net glucose in humans: the two carbons that enter citrate leave as CO2 in the isocitrate dehydrogenase and α-ketoglutarate dehydrogenase reactions.
Energy cost: 6 ATP equivalents per glucose from 2 pyruvate (pyruvate carboxylase 2 ATP, PEPCK 2 GTP, 3-phosphoglycerate kinase 2 ATP). That is why gluconeogenesis is a fasting, glucagon/cortisol, fatty-acid-oxidation-supported pathway.
Glycogen: synthesis, phosphorolysis, and the classic storage diseases
Glycogenesis. Glucose-6-phosphate → glucose-1-phosphate (phosphoglucomutase) → UDP-glucose (UDP-glucose pyrophosphorylase; pyrophosphate hydrolysis pulls). Glycogen synthase adds UDP-glucose to a nonreducing end with α-1,4 bonds; it needs a glycogenin primer. Branching enzyme (amylo-α-(1,4)→α-(1,6)-transglycosylase) moves a ~6–8 residue oligosaccharide to a C6-OH, creating a branch. Branches raise solubility and the number of nonreducing ends.
Glycogenolysis. Glycogen phosphorylase (pyridoxal phosphate) phosphorolyzes α-1,4 bonds to glucose-1-phosphate until four residues from a branch. Debranching enzyme has two activities: 4:4 transferase (moves the outer three glucoses) and 1,6-glucosidase (releases the branch-point glucose as free glucose, not G1P). Liver G6Pase then exports glucose. Muscle phosphorylase feeds glycolysis locally.
Hormone cascade you will see again in the enzyme section: glucagon (liver) or epinephrine (liver and muscle) → cAMP → PKA → phosphorylase kinase → phosphorylase a (active). The same PKA phosphorylates glycogen synthase to the inactive form. Insulin activates protein phosphatase-1, reversing both. Muscle phosphorylase is also opened by AMP and by Ca2+-calmodulin on phosphorylase kinase during contraction — so a contracting muscle dumps glycogen without waiting for a hormone.
| Disease | Enzyme | Organ | High-yield picture |
|---|---|---|---|
| von Gierke (I) | Glucose-6-phosphatase | Liver, kidney | Severe fasting hypoglycemia, lactic acidosis, hepatomegaly, hyperuricemia |
| Pompe (II) | Lysosomal acid α-glucosidase | Muscle, heart | Infantile hypotonia and cardiomyopathy; glycogen in lysosomes |
| Cori (III) | Debranching enzyme | Liver ± muscle | Hypoglycemia milder than I; short outer branches |
| Andersen (IV) | Branching enzyme | Liver | Long unbranched chains; cirrhosis |
| McArdle (V) | Muscle glycogen phosphorylase | Skeletal muscle | Exercise cramps, myoglobinuria; second-wind; no rise in lactate on ischemic forearm test |
| Hers (VI) | Liver glycogen phosphorylase | Liver | Mild hypoglycemia, hepatomegaly |
Pentose phosphate pathway, fructose, and galactose
Oxidative PPP (cytosol): glucose-6-phosphate dehydrogenase (G6PD, NADP+) → 6-phosphogluconolactone → 6-phosphogluconate dehydrogenase → ribulose-5-phosphate + CO2. Net per glucose-6-phosphate through both dehydrogenases: 2 NADPH + 1 CO2. NADPH is the reductant for fatty-acid and cholesterol synthesis and for glutathione reductase. RBCs have no other NADPH source; G6PD deficiency (X-linked) presents as hemolysis after primaquine, sulfa drugs, dapsone, infection, or fava beans. Heinz bodies and bite cells are the smear vocabulary.
Nonoxidative PPP: transketolase (thiamine pyrophosphate) and transaldolase shuffle 3–7 carbon sugars so the cell can make ribose-5-phosphate for nucleotides without NADPH, or make extra NADPH without ribose (recycle to F6P and GAP and re-enter glycolysis/gluconeogenesis). A transketolase assay with and without TPP is an old functional test of thiamine status.
Fructose. Hepatic fructokinase phosphorylates fructose to fructose-1-phosphate. Aldolase B splits F1P to DHAP and glyceraldehyde. That bypasses PFK-1, so a large fructose load can dump triose phosphates into liver and raise lipogenesis. Essential fructosuria (fructokinase) is benign — fructose spills in urine. Hereditary fructose intolerance (aldolase B) traps F1P, sequesters phosphate, stops glycogenolysis and gluconeogenesis, and causes hypoglycemia, liver injury, and aversion to sweets after weaning.
Galactose. Galactokinase → Gal-1-P. GALT (galactose-1-phosphate uridyltransferase) trades with UDP-glucose to make UDP-galactose + G1P. GALE epimerizes UDP-Gal/UDP-Glc. Classic galactosemia (GALT) : feeding a neonate milk produces liver failure, E. coli sepsis risk, cataracts (galactitol via aldose reductase), and Fanconi-type renal wasting. Galactokinase deficiency is mainly cataracts. Remove lactose; soy formulas are the practical move.
Ethanol is not a carbohydrate, but it wrecks carbohydrate numbers: alcohol dehydrogenase and aldehyde dehydrogenase generate NADH. High NADH drives oxaloacetate toward malate (starving gluconeogenesis), pyruvate toward lactate, and DHAP toward glycerol-3-phosphate (fatty liver). Fasting plus binge drinking → hypoglycemia and lactic acidosis. That item is carbohydrate regulation, not a bar-exam fact.
Which allosteric regulator is the principal feed-forward activator of hepatic phosphofructokinase-1 and falls when glucagon-driven protein kinase A phosphorylates the bifunctional PFK-2/FBPase-2 enzyme?
A patient with glucose-6-phosphate dehydrogenase deficiency develops hemolysis after primaquine. Which product of the oxidative pentose phosphate pathway is required to keep erythrocyte glutathione reduced?
Which enzyme catalyzes the mitochondrial first committed reaction that lets pyruvate enter gluconeogenesis, and which prosthetic group does that enzyme require?